Observation on the effect of transcutaneous electrical acupoint stimulation nursing on prevention of bone marrow suppression in patients with oral and maxillofacial tumors after chemotherapy
- Conditions
- Oral and Maxillofacial Tumors
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who were diagnosed as oral and maxillofacial tumors by pathology or cytology from January 1, 2021 to December 31, 2021;
2. Aged 18 to 80 years old, with basic cognitive ability;
3. Karnofsky (KPS) functional status score >=60 points, expected to survive for more than 3 months;
4. Those who have no severe heart, liver, brain, kidney and other organic damage and bone marrow hematopoietic dysfunction;
5. Check blood routine before chemotherapy, and evaluate patients whose bone marrow suppression score is 0 according to WHO's grading standard for side effects of chemotherapy;
6. The chemotherapy regimen is limited to the initial chemotherapy and the TPF regimen (docetaxel + cisplatin + 5-Fu) patients will not receive other chemotherapy drugs or concurrent radiotherapy during chemotherapy;
7. Sign the informed consent and get the approval of the ethics committee.
1. Complicated with hematological tumor;
2. People with mental illness;
3. Pregnant women;
4. Patients with myelosuppression before chemotherapy;
5. Patients with implanted on-demand pacemakers.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myelosuppression grade;White blood cell count;Neutrophil count;Red blood cell count;Anti-myelosuppressive medication;Platelet count;
- Secondary Outcome Measures
Name Time Method Quality of Life;cancer related fatigue;TCM body constitution;Comfort;